▶ 調査レポート

世界の経皮テストステロン市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Transdermal Testosterone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界の経皮テストステロン市場 2021:企業別、地域別、種類・用途別 / Global Transdermal Testosterone Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X17815資料のイメージです。• レポートコード:GIR-105X17815
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、95ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、経皮テストステロンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経皮テストステロンの種類別市場規模(ジェル、パッチ)、用途別市場規模(原発性性腺機能低下症、性腺機能低下性性腺機能低下症、遅発性性腺機能低下症)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・経皮テストステロンの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):AbbVie、Teva、Perrigo、Endo Pharmaceuticals、Acerus Pharmaceuticals、Lupin、Dr. Reddy's Laboratories、Upsher-Smith Laboratories、Allergan、Cipla Inc.
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ジェル、パッチ
・用途別分析2016年-2026年:原発性性腺機能低下症、性腺機能低下性性腺機能低下症、遅発性性腺機能低下症
・経皮テストステロンの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・経皮テストステロンのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・経皮テストステロンのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・経皮テストステロンの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・経皮テストステロンの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Transdermal Testosterone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Transdermal Testosterone size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Transdermal Testosterone market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Transdermal Testosterone market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Gel
Patch

Market segment by Application can be divided into
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism

The key market players for global Transdermal Testosterone market are listed below:
AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy’s Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Transdermal Testosterone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Testosterone, with price, sales, revenue and global market share of Transdermal Testosterone from 2019 to 2021.
Chapter 3, the Transdermal Testosterone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Testosterone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Transdermal Testosterone market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Transdermal Testosterone sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Transdermal Testosterone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transdermal Testosterone Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Gel
1.2.3 Patch
1.3 Market Analysis by Application
1.3.1 Overview: Global Transdermal Testosterone Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Global Transdermal Testosterone Market Size & Forecast
1.4.1 Global Transdermal Testosterone Sales in Value (2016-2026))
1.4.2 Global Transdermal Testosterone Sales in Volume (2016-2026)
1.4.3 Global Transdermal Testosterone Price by Type (2016-2026) & (USD/Unit)
1.5 Global Transdermal Testosterone Production Capacity Analysis
1.5.1 Global Transdermal Testosterone Total Production Capacity (2016-2026)
1.5.2 Global Transdermal Testosterone Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Transdermal Testosterone Market Drivers
1.6.2 Transdermal Testosterone Market Restraints
1.6.3 Transdermal Testosterone Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Transdermal Testosterone Product and Services
2.1.4 AbbVie Transdermal Testosterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Transdermal Testosterone Product and Services
2.2.4 Teva Transdermal Testosterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Perrigo
2.3.1 Perrigo Details
2.3.2 Perrigo Major Business
2.3.3 Perrigo Transdermal Testosterone Product and Services
2.3.4 Perrigo Transdermal Testosterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Endo Pharmaceuticals
2.4.1 Endo Pharmaceuticals Details
2.4.2 Endo Pharmaceuticals Major Business
2.4.3 Endo Pharmaceuticals Transdermal Testosterone Product and Services
2.4.4 Endo Pharmaceuticals Transdermal Testosterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Acerus Pharmaceuticals
2.5.1 Acerus Pharmaceuticals Details
2.5.2 Acerus Pharmaceuticals Major Business
2.5.3 Acerus Pharmaceuticals Transdermal Testosterone Product and Services
2.5.4 Acerus Pharmaceuticals Transdermal Testosterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Lupin
2.6.1 Lupin Details
2.6.2 Lupin Major Business
2.6.3 Lupin Transdermal Testosterone Product and Services
2.6.4 Lupin Transdermal Testosterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Dr. Reddy’s Laboratories
2.7.1 Dr. Reddy’s Laboratories Details
2.7.2 Dr. Reddy’s Laboratories Major Business
2.7.3 Dr. Reddy’s Laboratories Transdermal Testosterone Product and Services
2.7.4 Dr. Reddy’s Laboratories Transdermal Testosterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Upsher-Smith Laboratories
2.8.1 Upsher-Smith Laboratories Details
2.8.2 Upsher-Smith Laboratories Major Business
2.8.3 Upsher-Smith Laboratories Transdermal Testosterone Product and Services
2.8.4 Upsher-Smith Laboratories Transdermal Testosterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business
2.9.3 Allergan Transdermal Testosterone Product and Services
2.9.4 Allergan Transdermal Testosterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Cipla Inc.
2.10.1 Cipla Inc. Details
2.10.2 Cipla Inc. Major Business
2.10.3 Cipla Inc. Transdermal Testosterone Product and Services
2.10.4 Cipla Inc. Transdermal Testosterone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Transdermal Testosterone Sales by Manufacturer
3.1 Global Transdermal Testosterone Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Transdermal Testosterone Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Transdermal Testosterone
3.4 Market Concentration Rate
3.4.1 Top 3 Transdermal Testosterone Manufacturer Market Share
3.4.2 Top 6 Transdermal Testosterone Manufacturer Market Share
3.5 Global Transdermal Testosterone Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Transdermal Testosterone Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Transdermal Testosterone Market Size by Region
4.1.1 Global Transdermal Testosterone Sales in Volume by Region (2016-2026)
4.1.2 Global Transdermal Testosterone Revenue by Region (2016-2026)
4.2 North America Transdermal Testosterone Revenue (2016-2026)
4.3 Europe Transdermal Testosterone Revenue (2016-2026)
4.4 Asia-Pacific Transdermal Testosterone Revenue (2016-2026)
4.5 South America Transdermal Testosterone Revenue (2016-2026)
4.6 Middle East and Africa Transdermal Testosterone Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Transdermal Testosterone Sales in Volume by Type (2016-2026)
5.2 Global Transdermal Testosterone Revenue by Type (2016-2026)
5.3 Global Transdermal Testosterone Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Transdermal Testosterone Sales in Volume by Application (2016-2026)
6.2 Global Transdermal Testosterone Revenue by Application (2016-2026)
6.3 Global Transdermal Testosterone Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Transdermal Testosterone Sales by Type (2016-2026)
7.2 North America Transdermal Testosterone Sales by Application (2016-2026)
7.3 North America Transdermal Testosterone Market Size by Country
7.3.1 North America Transdermal Testosterone Sales in Volume by Country (2016-2026)
7.3.2 North America Transdermal Testosterone Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Transdermal Testosterone Sales by Type (2016-2026)
8.2 Europe Transdermal Testosterone Sales by Application (2016-2026)
8.3 Europe Transdermal Testosterone Market Size by Country
8.3.1 Europe Transdermal Testosterone Sales in Volume by Country (2016-2026)
8.3.2 Europe Transdermal Testosterone Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Transdermal Testosterone Sales by Type (2016-2026)
9.2 Asia-Pacific Transdermal Testosterone Sales by Application (2016-2026)
9.3 Asia-Pacific Transdermal Testosterone Market Size by Region
9.3.1 Asia-Pacific Transdermal Testosterone Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Transdermal Testosterone Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Transdermal Testosterone Sales by Type (2016-2026)
10.2 South America Transdermal Testosterone Sales by Application (2016-2026)
10.3 South America Transdermal Testosterone Market Size by Country
10.3.1 South America Transdermal Testosterone Sales in Volume by Country (2016-2026)
10.3.2 South America Transdermal Testosterone Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Transdermal Testosterone Sales by Type (2016-2026)
11.2 Middle East & Africa Transdermal Testosterone Sales by Application (2016-2026)
11.3 Middle East & Africa Transdermal Testosterone Market Size by Country
11.3.1 Middle East & Africa Transdermal Testosterone Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Transdermal Testosterone Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Transdermal Testosterone Typical Distributors
12.3 Transdermal Testosterone Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Transdermal Testosterone Revenue by Type, (USD Million), 2021-2026
Table 2. Global Transdermal Testosterone Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Transdermal Testosterone Product and Services
Table 6. AbbVie Transdermal Testosterone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Transdermal Testosterone Product and Services
Table 10. Teva Transdermal Testosterone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Perrigo Basic Information, Manufacturing Base and Competitors
Table 12. Perrigo Major Business
Table 13. Perrigo Transdermal Testosterone Product and Services
Table 14. Perrigo Transdermal Testosterone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Endo Pharmaceuticals Major Business
Table 17. Endo Pharmaceuticals Transdermal Testosterone Product and Services
Table 18. Endo Pharmaceuticals Transdermal Testosterone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Acerus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Acerus Pharmaceuticals Major Business
Table 21. Acerus Pharmaceuticals Transdermal Testosterone Product and Services
Table 22. Acerus Pharmaceuticals Transdermal Testosterone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Lupin Basic Information, Manufacturing Base and Competitors
Table 24. Lupin Major Business
Table 25. Lupin Transdermal Testosterone Product and Services
Table 26. Lupin Transdermal Testosterone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. Dr. Reddy's Laboratories Major Business
Table 29. Dr. Reddy's Laboratories Transdermal Testosterone Product and Services
Table 30. Dr. Reddy's Laboratories Transdermal Testosterone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Upsher-Smith Laboratories Basic Information, Manufacturing Base and Competitors
Table 32. Upsher-Smith Laboratories Major Business
Table 33. Upsher-Smith Laboratories Transdermal Testosterone Product and Services
Table 34. Upsher-Smith Laboratories Transdermal Testosterone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Allergan Basic Information, Manufacturing Base and Competitors
Table 36. Allergan Major Business
Table 37. Allergan Transdermal Testosterone Product and Services
Table 38. Allergan Transdermal Testosterone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cipla Inc. Basic Information, Manufacturing Base and Competitors
Table 40. Cipla Inc. Major Business
Table 41. Cipla Inc. Transdermal Testosterone Product and Services
Table 42. Cipla Inc. Transdermal Testosterone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Transdermal Testosterone Sales by Manufacturer (2019-2021e) & (K Units)
Table 44. Global Transdermal Testosterone Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Transdermal Testosterone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Transdermal Testosterone Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Transdermal Testosterone Production Site of Key Manufacturer
Table 48. Transdermal Testosterone New Entrant and Capacity Expansion Plans
Table 49. Transdermal Testosterone Mergers & Acquisitions in the Past Five Years
Table 50. Global Transdermal Testosterone Sales by Region (2016-2021e) & (K Units)
Table 51. Global Transdermal Testosterone Sales by Region (2021-2026) & (K Units)
Table 52. Global Transdermal Testosterone Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Transdermal Testosterone Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Transdermal Testosterone Sales by Type (2016-2021e) & (K Units)
Table 55. Global Transdermal Testosterone Sales by Type (2021-2026) & (K Units)
Table 56. Global Transdermal Testosterone Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Transdermal Testosterone Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Transdermal Testosterone Price by Type (2016-2021e) & (USD/Unit)
Table 59. Global Transdermal Testosterone Price by Type (2021-2026) & (USD/Unit)
Table 60. Global Transdermal Testosterone Sales by Application (2016-2021e) & (K Units)
Table 61. Global Transdermal Testosterone Sales by Application (2021-2026) & (K Units)
Table 62. Global Transdermal Testosterone Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Transdermal Testosterone Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Transdermal Testosterone Price by Application (2016-2021e) & (USD/Unit)
Table 65. Global Transdermal Testosterone Price by Application (2021-2026) & (USD/Unit)
Table 66. North America Transdermal Testosterone Sales by Country (2016-2021e) & (K Units)
Table 67. North America Transdermal Testosterone Sales by Country (2021-2026) & (K Units)
Table 68. North America Transdermal Testosterone Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Transdermal Testosterone Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Transdermal Testosterone Sales by Type (2016-2021e) & (K Units)
Table 71. North America Transdermal Testosterone Sales by Type (2021-2026) & (K Units)
Table 72. North America Transdermal Testosterone Sales by Application (2016-2021e) & (K Units)
Table 73. North America Transdermal Testosterone Sales by Application (2021-2026) & (K Units)
Table 74. Europe Transdermal Testosterone Sales by Country (2016-2021e) & (K Units)
Table 75. Europe Transdermal Testosterone Sales by Country (2021-2026) & (K Units)
Table 76. Europe Transdermal Testosterone Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Transdermal Testosterone Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Transdermal Testosterone Sales by Type (2016-2021e) & (K Units)
Table 79. Europe Transdermal Testosterone Sales by Type (2021-2026) & (K Units)
Table 80. Europe Transdermal Testosterone Sales by Application (2016-2021e) & (K Units)
Table 81. Europe Transdermal Testosterone Sales by Application (2021-2026) & (K Units)
Table 82. Asia-Pacific Transdermal Testosterone Sales by Region (2016-2021e) & (K Units)
Table 83. Asia-Pacific Transdermal Testosterone Sales by Region (2021-2026) & (K Units)
Table 84. Asia-Pacific Transdermal Testosterone Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Transdermal Testosterone Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Transdermal Testosterone Sales by Type (2016-2021e) & (K Units)
Table 87. Asia-Pacific Transdermal Testosterone Sales by Type (2021-2026) & (K Units)
Table 88. Asia-Pacific Transdermal Testosterone Sales by Application (2016-2021e) & (K Units)
Table 89. Asia-Pacific Transdermal Testosterone Sales by Application (2021-2026) & (K Units)
Table 90. South America Transdermal Testosterone Sales by Country (2016-2021e) & (K Units)
Table 91. South America Transdermal Testosterone Sales by Country (2021-2026) & (K Units)
Table 92. South America Transdermal Testosterone Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Transdermal Testosterone Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Transdermal Testosterone Sales by Type (2016-2021e) & (K Units)
Table 95. South America Transdermal Testosterone Sales by Type (2021-2026) & (K Units)
Table 96. South America Transdermal Testosterone Sales by Application (2016-2021e) & (K Units)
Table 97. South America Transdermal Testosterone Sales by Application (2021-2026) & (K Units)
Table 98. Middle East & Africa Transdermal Testosterone Sales by Country (2016-2021e) & (K Units)
Table 99. Middle East & Africa Transdermal Testosterone Sales by Country (2021-2026) & (K Units)
Table 100. Middle East & Africa Transdermal Testosterone Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Transdermal Testosterone Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Transdermal Testosterone Sales by Type (2016-2021e) & (K Units)
Table 103. Middle East & Africa Transdermal Testosterone Sales by Type (2021-2026) & (K Units)
Table 104. Middle East & Africa Transdermal Testosterone Sales by Application (2016-2021e) & (K Units)
Table 105. Middle East & Africa Transdermal Testosterone Sales by Application (2021-2026) & (K Units)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Transdermal Testosterone Typical Distributors
Table 109. Transdermal Testosterone Typical Customers
List of Figures
Figure 1. Transdermal Testosterone Picture
Figure 2. Global Transdermal Testosterone Sales Market Share by Type in 2020
Figure 3. Gel
Figure 4. Patch
Figure 5. Global Transdermal Testosterone Sales Market Share by Application in 2020
Figure 6. Primary Hypogonadism
Figure 7. Hypogonadotropic Hypogonadism
Figure 8. Late-Onset Hypogonadism
Figure 9. Global Transdermal Testosterone Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Transdermal Testosterone Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Transdermal Testosterone Sales (2016-2026) & (K Units)
Figure 12. Global Transdermal Testosterone Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Transdermal Testosterone Production Capacity (2016-2026) & (K Units)
Figure 14. Global Transdermal Testosterone Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Transdermal Testosterone Market Drivers
Figure 16. Transdermal Testosterone Market Restraints
Figure 17. Transdermal Testosterone Market Trends
Figure 18. Global Transdermal Testosterone Sales Market Share by Manufacturer in 2020
Figure 19. Global Transdermal Testosterone Revenue Market Share by Manufacturer in 2020
Figure 20. Transdermal Testosterone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Transdermal Testosterone Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Transdermal Testosterone Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Transdermal Testosterone Sales Market Share by Region (2016-2026)
Figure 24. Global Transdermal Testosterone Revenue Market Share by Region (2016-2026)
Figure 25. North America Transdermal Testosterone Revenue (2016-2026) & (USD Million)
Figure 26. Europe Transdermal Testosterone Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Transdermal Testosterone Revenue (2016-2026) & (USD Million)
Figure 28. South America Transdermal Testosterone Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Transdermal Testosterone Revenue (2016-2026) & (USD Million)
Figure 30. Global Transdermal Testosterone Sales Market Share by Type (2016-2026)
Figure 31. Global Transdermal Testosterone Revenue Market Share by Type (2016-2026)
Figure 32. Global Transdermal Testosterone Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Transdermal Testosterone Sales Market Share by Application (2016-2026)
Figure 34. Global Transdermal Testosterone Revenue Market Share by Application (2016-2026)
Figure 35. Global Transdermal Testosterone Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Transdermal Testosterone Sales Market Share by Type (2016-2026)
Figure 37. North America Transdermal Testosterone Sales Market Share by Application (2016-2026)
Figure 38. North America Transdermal Testosterone Sales Market Share by Country (2016-2026)
Figure 39. North America Transdermal Testosterone Revenue Market Share by Country (2016-2026)
Figure 40. United States Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Transdermal Testosterone Sales Market Share by Type (2016-2026)
Figure 44. Europe Transdermal Testosterone Sales Market Share by Application (2016-2026)
Figure 45. Europe Transdermal Testosterone Sales Market Share by Country (2016-2026)
Figure 46. Europe Transdermal Testosterone Revenue Market Share by Country (2016-2026)
Figure 47. Germany Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Transdermal Testosterone Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Transdermal Testosterone Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Transdermal Testosterone Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Transdermal Testosterone Revenue Market Share by Region (2016-2026)
Figure 56. China Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Transdermal Testosterone Sales Market Share by Type (2016-2026)
Figure 63. South America Transdermal Testosterone Sales Market Share by Application (2016-2026)
Figure 64. South America Transdermal Testosterone Sales Market Share by Country (2016-2026)
Figure 65. South America Transdermal Testosterone Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Transdermal Testosterone Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Transdermal Testosterone Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Transdermal Testosterone Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Transdermal Testosterone Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Transdermal Testosterone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source